Emerging drugs for small-cell lung cancer

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Targeting Mammalian Target of Rapamycin Synergistically Enhances Chemotherapy-Induced Cytotoxicity in Breast Cancer Cells2004 · 321 citations
2. 2VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development1996 · 698 citations
3. 3Phase I Pharmacokinetic and Biologic Correlative Study of Mapatumumab, a Fully Human Monoclonal Antibody With Agonist Activity to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor-12007 · 314 citations
4. 4Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer2009 · 92 citations